source: by Timothy Hay When the Food and Drug Administration told personal-genetics company 23andMe Inc. in November to stop sending consumers detailed information about their DNA, some industry watchers said the move could be a devastating blow to an emerging area of medicine that holds promise for better health outcomes. But it was more of […]
Read MoreOur portfolio company Assurex Health just announced the creation of a partnership with Canada’s Center for Addiction and Mental Health (CAMH), one of the world’s leading research centers in the area of addiction and mental health and Canada’s largest mental health teaching hospital. CAMH will offer to Canadian citizens the firm’s pharmacogenomic test, GeneSight, which […]
Read MoreOur portfolio company Assurex Health, announced recently the publication of a groundbreaking analysis of pharmacogenomic data in the International Review of Psychiatry. The publication strongly validates the premise that the clinical use of genomic testing to help predict patient response to psychiatric medications significantly improves treatment outcomes. This is a key milestone in the continuing […]
Read MoreCongratulations to our portfolio company Assurex Health which appointed Consumer Products Executive Virginia Coleman Drosos President to Lead the company. We are so excited to have her in this position and wish her all the best.
Read MoreBloomberg reporter Ryan Flinn recently wrote an article on Brain Scans Seek Best Drug Match for Depression Patients. The article summarizes some of the technologies that are being used by clinicians to assist in diagnosis and treatment of depression, and focused on technologies provided by two companies. The first company profiled uses a technology that matches […]
Read MoreClaremont Creek Ventures portfolio company AssureRx Health continues to receive good press. Below are some excerpts from a recent FoxNews article published June 19, 2012. Read the full article at FoxNews.com Genetic testing to choose the right antidepressant By Dr. Keith Ablow. Psychiatrists often try two or more medications in a patient suffering with major depression […]
Read MoreClaremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.